INTRODUCTION
============

During the last years, several oxidative stress-sensing pathways responding to fluctuations in hydrogen peroxide (H~2~O~2~) have been described. At least two independent but cross-talking pathways, that of the MAP kinase Sty1/Spc1 (with its downstream transcription factor Atf1) and the Pap1 pathways, are activated upon increased intracellular concentrations of H~2~O~2~ in the fission yeast *Schizosaccharomyces pombe*. The b-ZIP-containing transcription factor Pap1, homologue of mammalian c-Jun (*[p]{.ul}ombe* [AP]{.ul}-1), is essential for normal tolerance to peroxides ([@gks141-B1],[@gks141-B2]). In response to non-toxic doses of H~2~O~2~ (extracellular 70--200 μM), Pap1 triggers \>2-fold the transcription of 50 genes ([@gks141-B3]). Many Pap1-dependent gene products are meant to scavenge reactive oxygen species (such as catalase, the peroxiredoxin Tpx1, the sulfiredoxin Srx1 or superoxide dismutase) ([@gks141-B3; @gks141-B4; @gks141-B5; @gks141-B6]), or reverse the oxidative burst (such as thioredoxin, thioredoxin reductase or some glutaredoxins) ([@gks141-B7]). However, other genes coding for efflux pumps, dehydrogenases, etc., seem to be involved in the cellular defence against multiple drugs (see below).

The molecular mechanisms underlying Pap1 activation are still focus of study. The transcription factor has a hypothetical double nuclear import signal (NLS) and a nuclear export signal (NES), which are recognized by the importin-α Imp1 ([@gks141-B8]) and the exportin Crm1 ([@gks141-B9]), respectively. The Crm1-dependent export of Pap1 prevails over the import, and therefore the transcription factor displays cytosolic localization prior to stress imposition ([@gks141-B10]). In response to H~2~O~2~, at least one intramolecular disulfide bond between two cysteine residues is formed in Pap1, which hinders its NES from the nuclear exporter Crm1, resulting in transient Pap1 nuclear accumulation and in Pap1-dependent gene expression ([@gks141-B9],[@gks141-B11],[@gks141-B12]). Oxidation of Pap1 by H~2~O~2~ requires the participation of the peroxide scavenger/sensor Tpx1 ([@gks141-B6],[@gks141-B13]), and it has been postulated that the thioredoxin--thioredoxin reductase system contribute to both maintaining Pap1 in a reduced state in the absence of stress and returning it in to the inactive/reduced/cytoplasmic form once the gene response has been engaged ([@gks141-B12],[@gks141-B14]).

Activation of Pap1-dependent antioxidant genes by H~2~O~2~ is essential to confer wild-type tolerance to the oxidant, as shown on solid plates and in liquid cultures ([@gks141-B2],[@gks141-B10]). But, in fact, Pap1 was first isolated as conferring resistance to multiple drugs, such as brefeldin A, staurosporine or caffeine, when constitutively activated or over-expressed ([@gks141-B1],[@gks141-B15],[@gks141-B16]). Multidrug resistant phenotypes are often associated to constitutive activation of oxidative stress signalling pathways in several microbes. We have recently reported that the Pap1-dependent efflux pumps Hba2 and Caf5, two ABC-family transporters, are essential to trigger normal tolerance to caffeine, probably acting as efflux pumps to extrude this and other drugs from the intracellular compartment ([@gks141-B17]).

In general, three different strategies have been described to confer Pap1-dependent resistance to several drugs ([Figure 1](#gks141-F1){ref-type="fig"}A): (i) constitutive oxidation of Pap1 by deletion of the thioredoxin reductase gene; in this particular case, Pap1 export is blocked since the protein is locked in the oxidized conformation; (ii) over-expression of the protein, with concomitant enhancement of Pap1-dependent transcription; this can be genetically accomplished by depletion of a subunit of the 26S proteasome, Pad1 ([@gks141-B16],[@gks141-B18]), or deletion of the *ubr1* gene, encoding a ubiquitin ligase which regulates nuclear Pap1 stability ([@gks141-B19]); (iii) inhibition of Pap1 nuclear export, either by chemical- ([@gks141-B9]) or temperature-([@gks141-B10]) dependent inactivation of the essential Crm1 protein, or by depletion of the Crm1 cofactor Hba1 ([@gks141-B20]). We demonstrate here that, unexpectedly, this gain of drug resistance does not correlate with enhanced tolerance to oxidative stress. In fact, defects in nuclear export render Pap1 being insensitive to H~2~O~2~-mediated oxidation, probably due to the cytoplasmic localization of its upstream redox transmitter, Tpx1. Analysis of the transcriptome of these constitutively nuclear-expressing cell types indicate that the drug tolerance genes are being activated under basal conditions, but not the antioxidant ones. In fact, we have determined that only oxidized nuclear Pap1, but not the reduced one, interacts with the transcription regulator Prr1 and activates also antioxidant genes. The distinct regulation of these two subsets of genes may reflect an evolutionary merge of previous and independent oxidative stress and multidrug resistance responses. Figure 1.Genetic inhibition of Pap1 export renders a transcription factor insensitive to H~2~O~2~ stress. (**A**) Schematic representation of Pap1 activation by H~2~O~2~. Upon peroxide stress, Tpx1 mediates disulfide bond formation in Pap1, which hinders the recognition by the exportin Crm1 and its cofactor Hba1 to the Pap1 NES. Nuclear accumulation of oxidized Pap1 triggers transcription both antioxidant and drug resistance genes. The relative position of the seven cysteines residues (C) in Pap1 is indicated. (**B**) Localization of Pap1 in wild-type and mutant strains. The cellular distribution of GFP-Pap1 was determined by fluorescence microscopy in EHH14 (WT), EHH14.C523D (Pap1.C523D), AV19 (Δ*trr1*) and EA33 (Δ*hba1*) treated or not with 0.2 mM H~2~O~2~ for 5 min. (**C**) Constitutively nuclear Pap1 confers resistant to caffeine but not to H~2~O~2~. Strains IC2 (WT), IC1 (Δ*pap1*), NG25 (Δ*trr1*), IC2.C523D (*pap1.C523D*) and *caf1*::*ura4*^+^ (Δ*hba1*) were grown in liquid YE media, and the indicated number of cells were spotted onto plates with or without 2 mM H~2~O~2~ or 15 mM caffeine. (**D**) *In vivo* oxidation of Pap1 in wild-type and mutant strains. Strains IC2 (WT), NG25 (Δ*trr1*), IC2.C523D (*pap1.C523D*) and *caf1*::*ura4*^+^ (Δ*hba1*) were treated or not with 0.2 mM H~2~O~2~ for 5 min. TCA extracts were processed by non-reducing SDS--PAGE and analysed by western blot with antibodies against Pap1. Reduced/inactive (red. Pap1) and oxidized/active (ox. Pap1) Pap1 forms are indicated with arrows.

MATERIALS AND METHODS
=====================

Yeast strains and growth conditions
-----------------------------------

The origins and genotypes of strains used in this study are outlined in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1). Cells were grown in rich medium (YE) or in synthetic minimal medium as described previously ([@gks141-B21]).

Plasmids
--------

The integrative plasmid p85.41x ([@gks141-B11]) was used to generate a Δ*prr1* strain expressing GFP-Pap1. The *prr1* coding sequence was PCR-amplified from *S. pombe* cDNA using specific primers and cloned into the *nmt* (*[n]{.ul}o [m]{.ul}essage in [t]{.ul}hiamine*)-driven expression vector pREP.41 ([@gks141-B22]) to yield plasmid p397.41.

RNA analysis
------------

Total RNA from *S. pombe* minimal media cultures was obtained, processed and transferred to membranes as described previously ([@gks141-B11]). Membranes were hybridized with \[α-^32^P\] dCTP-labelled *caf5*, *obr1*, *SPCC663.08c*, *trr1*, *srx1* or *ctt1* probes, containing the complete open reading frames. We used ribosomal RNA, *tfb2* or *act1* as loading controls.

H~2~O~2~ sensitivity assay
--------------------------

For survival on solid plates, *S. pombe* strains were grown, diluted and spotted in YE5S media agar plates as described previously ([@gks141-B17]), containing 2 mM H~2~O~2~ or 15 mM caffeine.

Preparation of *S. pombe* TCA extracts and immunoblot analysis
--------------------------------------------------------------

To analyse the *in vivo* redox state of Pap1, trichloroacetic acid (TCA) extracts were prepared as described elsewhere ([@gks141-B6]). Immunoblotting was performed as described previously ([@gks141-B23]). Pap1 was immunodetected using polyclonal anti-Pap1 antibody ([@gks141-B12]). A similar protocol but without alkaline phosphatase treatment was followed to obtain TCA extracts to detect Prr1-HA. Immunoblotting was performed using monoclonal anti-HA antiserum (12CA5).

Fluorescence microscopy
-----------------------

Fluorescence microscopy and image capture was performed as described before ([@gks141-B12]).

Chromatin immunoprecipitation
-----------------------------

To test the binding of Pap1 and Prr1 to all six promoters, the indicated strains were grown in minimal media, and chromatin isolation and immunoprecipitation was performed as described previously ([@gks141-B24]) but with 10 min instead of 20 min for cross-linking and 1 μl of polyclonal anti-Pap1 and monoclonal anti-HA antiserum (12CA5) (40 and 10 μg, respectively, of each antiserum). Also, the specific primers for Pap1 dependent genes, amplifying promoters, corresponded to the following positions with respect to the translation initiation sites: −222 to −117 of the *trr1* gene; −359 to −258 of the *srx1* gene; −506 to −403 of the *ctt1* gene; −238 to −164 of the *caf5* gene; −398 to −322 of the *obr1* gene and −121 to −44 of the *SPCC663.08c* gene. Control primers, spanning an intergenic region of *S. pombe* chromosome I (position 465 226 to 465 326) were also used. Results were expressed as a percentage of the input. The error bars (SD) were calculated from biological triplicates.

Co-immunoprecipitation analysis
-------------------------------

Cells from 100 ml of rich media cultures at an OD~600~ of 0.5 (1 × 10^7^ cells) were pelleted and re-suspended in lysis buffer (10 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40), and lysed with two 60-s pulses in a cryogenic grinder (6770 Freezer/Mill; SPEX SamplePrep). Lysates were centrifuged for 5 min at 6000*g* and supernatants transferred to fresh microtubes. Prr1-GFP was immunoprecipitated from cleared supernatants by adding 10 μl of GFP-Trap beads (Chromotek) for 1 h at 4°C. Immunoprecipitates were washed twice with dilution buffer (10 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA), and samples were then treated with 0.04 U/µl of alkaline phosphatase for 30 min at 37°C, to avoid broad bands after electrophoresis. Proteins were released from immunocomplexes by boiling for 5 min in sodium dodecyl sulfate (SDS) loading buffer. Samples were separated by 8% SDS--polyacrylamide gel electrophoresis (PAGE) and detected by immunoblotting with polyclonal anti-Pap1 ([@gks141-B12]) or anti-GFP antiserum, raised against a fusion protein GST-GFP purified from *E. coli*, following standard rabbit immunization procedures.

RESULTS
=======

Cells expressing constitutively nuclear Pap1, regardless of its oxidation state, are resistant to multiple drugs but not to oxidative stress
--------------------------------------------------------------------------------------------------------------------------------------------

While Pap1 has been designed to remain in the cytosol in the absence of oxidative stress ([Figure 1](#gks141-F1){ref-type="fig"}A), induction of its oxidation by deletion of the thioredoxin reductase-coding gene can render a constitutively oxidized and nuclear Pap1 (*Δtrr1*, [Figure 1](#gks141-F1){ref-type="fig"}B and D). Alternatively, defects in the Crm1-dependent export machinery (i.e. cells lacking the Crm1 cofactor Hba1) or alteration of the NES in Pap1 (i.e. Cys-to-Asp mutation of residue 523 of Pap1, expressed from the *pap1* chromosomal locus) can block Pap1 in the nucleus in the absence of stress ([Figure 1](#gks141-F1){ref-type="fig"}B). In all three cases (*Δtrr1, Δhba1* and *pap1.C523D* strains), constitutively nuclear Pap1 significantly enhances *S. pombe* resistance to caffeine, as previously described ([Figure 1](#gks141-F1){ref-type="fig"}C). Unexpectedly, while cells lacking Trr1 display some sensitivity to peroxides probably due to the lack of an active thioredoxin reducing system, cells lacking Hba1 or expressing constitutively nuclear Pap1.C523D are not resistant to peroxides, and, in fact, display more sensitivity than wild-type cells ([Figure 1](#gks141-F1){ref-type="fig"}C).

Constitutively nuclear Pap1 is not sensitive to oxidation by H~2~O~2~
---------------------------------------------------------------------

We analysed the redox state of Pap1 in the four strain backgrounds. As shown before, *Δtrr1* cells display oxidized Pap1 even prior to stress, what explains its constitutively nuclear localization ([@gks141-B12]) ([Figure 1](#gks141-F1){ref-type="fig"}D). Surprisingly, inhibition of Pap1 export by mutating the NES or by Hba1 depletion renders a constitutively nuclear Pap1 which is unable to become oxidized in the presence of H~2~O~2~ stress ([Figure 1](#gks141-F1){ref-type="fig"}D). We have determined that Tpx1, the H~2~O~2~ sensor that initiates the redox relay towards Pap1 ([Figure 1](#gks141-F1){ref-type="fig"}A), has cytoplasmic localization (our unpublished data), and we suspect that this may cause the inability of constitutively nuclear Pap1 to become oxidized in the presence of peroxide stress; that explains why cells expressing constitutively reduced Pap1 have more sensitivity to H~2~O~2~ than wild-type cells (compare WT to *pap1.C523D* or *Δhba1;* [Figure 1](#gks141-F1){ref-type="fig"}C).

Constitutively nuclear Pap1 can bind and activate a subset of Pap1-dependent genes
----------------------------------------------------------------------------------

We decided to study how constitutively nuclear Pap1 altered the pattern of induction of the transcriptional response to peroxides. We analysed by northern blot the activation of several genes which expression is strongly triggered in a Pap1-dependent manner by low doses of H~2~O~2~: the *ctt1, srx1* and *trr1* genes, coding for important antioxidant activities (catalase, sulfiredoxin and thioredoxin reductase, respectively); and the *caf5*, *obr1*, and *SPCC663.08c*, coding for an ABC-containing efflux pump, an ubiquitinated histone-like protein and a putative dehydrogenase, respectively. As observed in [Figure 2](#gks141-F2){ref-type="fig"}A, cells lacking Trr1 (and therefore expressing oxidized nuclear Pap1) display constitutive expression of all Pap1-dependent genes (except *trr1*), whereas cells expressing constitutively reduced and nuclear Pap1 (*pap1.C523D)* only display constitutive activation of *caf5, obr1* and *SPCC663.08c*, and are unable to trigger the antioxidant genes upon stress. Similar results were observed in cells lacking Hba1 ([Supplementary Figure S1A](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)). Figure 2.Constitutively reduced/nuclear Pap1 can only bind and activate a subset of Pap1-dependent genes. (**A**) Stress-dependent transcriptional analysis of wild-type and mutant strains. Cultures of strains IC2 (WT), IC1 (Δ*pap1*), NG25 (Δ*trr1*) and IC2.C523D (*pap1.C523D*) were treated or not with 0.2 mM H~2~O~2~ for the indicated times. Total RNA was obtained and analysed by northern blot with probes for *trr1, srx1, ctt1, caf5, obr1* and *SPCC663.08 c*. Ribosomal RNA (rRNAs) and *tfb2* are shown as loading controls. (**B**) Oxidized/nuclear Pap1 is recruited to all Pap1-dependent promoters. Cultures of the strains used in [Figure 2](#gks141-F2){ref-type="fig"}A were treated with 0.2 mM H~2~O~2~ for 5 min. ChIP experiments using anti-Pap1 antibody, coupled to quantification by real-time PCR, were performed using primers covering only promoter regions of *trr1, srx1, ctt1, caf5, obr1* and *SPCC663.08c* genes. Primers of an intergenic region were used as a negative control (control). Error bars (SD) for all ChIP experiments were calculated from biological triplicates.

Reduced Pap1, when located in the nucleus, was therefore unable to trigger RNA polymerase II-dependent transcription at some promoters. To test whether reduced/nuclear Pap1 was capable of binding DNA *in vivo*, we used chromatin immunoprecipitation (ChIP) assay at all six promoters, and observed that oxidized/nuclear Pap1 constitutively binds to both sets of promoters (*Δtrr1*, [Figure 2](#gks141-F2){ref-type="fig"}B left and right panels). On the contrary, reduced/nuclear Pap1 constitutively binds to the *obr1*, *caf5* and *SPCC663.08c* promoters (*pap1.C523D*, [Figure 2](#gks141-F2){ref-type="fig"}B, left panel), but not to the antioxidant promoters (*pap1.C523D*, [Figure 2](#gks141-F2){ref-type="fig"}B, right panel). Similar results were observed in cells lacking Hba1 ([Supplementary Figure S1B](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)). It is worth mentioning that the phenotypes of strain *Δhba1* are less severe than that of cells expressing Pap1.C523D, probably due to the non-essential character of Hba1 regarding Crm1-mediated export.

The transcription factor Prr1 is essential for Pap1-dependent activation of the antioxidant, but not the drug tolerance, genes
------------------------------------------------------------------------------------------------------------------------------

We have established that there are at least two subsets of Pap1-dependent genes: the drug resistance ones only require nuclear Pap1, independent of its redox state, whereas the antioxidant genes need Pap1 to be oxidized as well. We decided to search for other transcription factors which could mediate this different pattern of gene induction. The response regulator Prr1, homologous to the *Saccharomyces cerevisiae* SKN7, has been shown to be important for the oxidative stress response in *S. pombe*, since a strain lacking this transcription factor is very sensitive to H~2~O~2~ ([@gks141-B25]) ([Figure 3](#gks141-F3){ref-type="fig"}A). In its absence, induction of some Sty1-Atf1- and/or Pap1-dependent genes is severely compromised ([@gks141-B25],[@gks141-B26]). Figure 3.The response regulator Prr1 is required for the activation of the antioxidant, but not the drug resistance Pap1-dependent genes. (**A**) Prr1 is sensitive to H~2~O~2~ stress~.~ Serial dilutions from cultures of strains IC2 (WT), IC1 (Δ*pap1*), MS46 (Δ*atf1*), MC16 (Δ*prr1*) and MC18 (Δ*pap1Δprr1*) were spotted onto rich plates with or without H~2~O~2~. (**B**) Prr1 has constitutively nuclear localization. The cellular distribution of Pap1 or Prr1 was determined by fluorescence microscopy of strains MC41 (*prr1-GFP*), MC42 (*pap1-GFP*), IC81 (Δ*prr1* with integrative *nmt::GFP-pap1*) and IC83 (Δ*pap1 prr1-GFP*) treated or not with 0.2 mM H~2~O~2~ for 5 min. (**C**) Northern blot analysis of Pap1-dependent genes. Total RNA from strains IC2 (WT) and MC16 (Δ*prr1*) was obtained from cultures treated with 0.2 mM H~2~O~2~ for the indicated times, and analysed as described in [Figure 2](#gks141-F2){ref-type="fig"}A. (**D**) *In vivo* oxidation of Pap1 is Prr1-independent. The redox state of Pap1 in IC2 (WT) and MC16 (Δ*prr1*) strains, and of Prr1 in MC40 (*prr1-HA*) and IC64 (Δ*pap1 prr1-HA)* strains were analysed by western blot after non-reducing electrophoresis, with or without stress. (**E**) ChIP analysis of Pap1 recruitment to stress promoters in strains IC2 (WT) and MC16 (Δ*prr1*) was performed as described in [Figure 2](#gks141-F2){ref-type="fig"}B.

To deeply characterize the function of Prr1 regarding Pap1-dependent gene induction, we first determined that Prr1, which is constitutively nuclear regardless the presence of Pap1, did not affect the nuclear accumulation of Pap1 upon H~2~O~2~ stress ([Figure 3](#gks141-F3){ref-type="fig"}B). Importantly enough, the absence of Prr1 allowed H~2~O~2~-dependent activation of *caf5, obr1* and *SPCC663.08c*, but not of the antioxidant genes ([Figure 3](#gks141-F3){ref-type="fig"}C). Since those are the genes which require oxidized Pap1 for activation ([Figure 2](#gks141-F2){ref-type="fig"}A), we tested whether Prr1 was affecting Pap1 oxidation in the presence of peroxides. As shown in [Figure 3](#gks141-F3){ref-type="fig"}D, cells lacking Prr1 were perfectly able to oxidize Pap1. However, whereas the binding of Pap1 to the drug tolerance genes was unaffected in *Δprr1* cells ([Figure 3](#gks141-F3){ref-type="fig"}E, left panel), its recruitment to the antioxidant genes was severely impaired ([Figure 3](#gks141-F3){ref-type="fig"}E, right panel). We conclude that Prr1 facilitates binding of oxidized Pap1 to one subset of promoters, but not to the other.

We then analysed the capacity of Prr1 to bind to both sets of promoters by ChIP. As observed in [Figure 4](#gks141-F4){ref-type="fig"}A, Prr1 is recruited to all six promoters after mild oxidative stress in a Pap1-dependent manner. Importantly enough, Pap1 is only able to drag Prr1 to DNA in its oxidized form: cells lacking Trr1 constitutively display Prr1 bound to all promoters, whereas in cells expressing Pap1.C523D, which is nuclear and cannot become oxidized, Prr1 is not detected at DNA either before or after stress imposition ([Figure 4](#gks141-F4){ref-type="fig"}B). Figure 4.Prr1 is recruited to all Pap1-dependent promoters in an oxidized Pap1-dependent manner. (**A**) Strains MC40 (*prr1-HA*) and IC64 (Δ*pap1 prr1-HA*) were treated or not with 0.2 mM H~2~O~2~ for 5 min. ChIP of Prr1 using anti-HA antibody was performed as described in [Figure 2](#gks141-F2){ref-type="fig"}B. (**B**) Same as in [Figure 4](#gks141-F4){ref-type="fig"}A, with strains MC40 (*prr1-HA*), PG7 (Δ*trr1 prr1-HA*) and PG3 (*pap1.C523D prr1-HA*).

Oxidized Pap1 interacts with Prr1, and that interaction is required for the activation of antioxidant genes
-----------------------------------------------------------------------------------------------------------

Our experiments predict that oxidized Pap1 may form a complex with Prr1 at the nucleus, and that such association may be required for binding of Pap1 to some, but not all, promoters. We first evaluated the relative concentrations of cellular Pap1 and Prr1 by tagging each gene at their chromosomal loci with either HA or GFP, and therefore maintaining their own promoters. Dismissing a putative effect of both HA and GFP tags on protein stability, the amount of cellular Prr1 is slightly higher than that of Pap1 ([Figure 5](#gks141-F5){ref-type="fig"}A), what would suggest that all Pap1 molecules, once accumulated at the nucleus, could potentially associate to Prr1 *in vivo*. We then tested whether Pap1 and Prr1 interact *in vivo* by immunoprecipitating Prr1-GFP, and using polyclonal antibodies against Pap1. The Prr1-GFP-expressing strain was completely wild-type regarding gene induction and sensitivity to peroxides (data not shown). As shown in [Figure 5](#gks141-F5){ref-type="fig"}B, a clear co-immunoprecipitation between Prr1-GFP and Pap1 was detected only after stress imposition. Importantly enough, only oxidized/nuclear Pap1 was able to interact with Prr1, since cells lacking Hba1 or expressing the non-exportable Pap1.C523D protein did not co-immunoprecipitate ([Figure 5](#gks141-F5){ref-type="fig"}B and C). On the contrary, the association between Prr1-GFP and Pap1 was constitutive in *Δtrr1* cells, where Pap1 is oxidized even prior to stress imposition ([Figure 5](#gks141-F5){ref-type="fig"}C). Figure 5.Oxidized Pap1 and Prr1 interact *in vivo*. (**A**) Pap1 and Prr1 are expressed at similar levels in cells. Pap1 and Prr1 were tagged at their genomic loci with HA (upper panel) or GFP (lower panel), and protein concentration was compared from 10 μg of total TCA extracts of strains IC70 (1; *pap1-HA)*, MC40 (2; *prr1-HA*), MC42 (3; *pap1-GFP*) and MC41 (4; *prr1-GFP)* by western blot using antibodies against HA or GFP*.* **(B** and **C)** Pap1 and Prr1-GFP interact *in vivo* after H~2~O~2~ stress. Strains 972 (WT), IC83 (Δ*pap1 prr1-GFP*), MC41 (WT *prr1-GFP*), IC97 (Pap1.C523D *prr1-GFP*), PG20 (Δ*hba1 prr1-GFP*) and IC102 (Δ*trr1 prr1-GFP*) were treated (+) or not (−) for 5 min with 0.2 mM H~2~O~2~. Native extracts were obtained, and 2 mg of total protein extracts were immunoprecipitated with GFP-trap beads. The resulting immunoprecipitates were analysed by SDS--PAGE and blotted with anti-Pap1 or anti-GFP antibodies. As a loading control, 40 µg of whole-cell extracts were loaded (WCE).

DISCUSSION
==========

Components of oxidative stress signalling pathways have often been isolated in screens of general drug resistance, since several of these regulons include genes reported to contribute to drug export or detoxification. Here, we show that the Pap1-dependent gene expression program can be classified into two different and not overlapping subsets. The first one codes for activities responsible for multidrug resistance, and are triggered by nuclear Pap1, irrespective of its oxidation state. The second one, which includes traditional antioxidant genes, is only engaged by oxidized Pap1, which then binds to Prr1 and recognizes these promoters ([Figure 6](#gks141-F6){ref-type="fig"}). Figure 6.Association of oxidized Pap1 and Prr1 is required for the activation of the antioxidant, but not the drug resistance, genes. (**A**) In wild-type cells, oxidation of Pap1 upon H~2~O~2~ stress induces its nuclear accumulation and its association with Prr1. The heterodimer is then able to activate both sets of promoters, the antioxidant (*trr1, srx1, ctt1*) and the drug resistance (*obr1, caf5, c663.08c*) genes. (**B**) In cells defective in Pap1 export (such as cells lacking Hba1 or expressing Pap1.C523D), the transcription factor cannot be oxidized by H~2~O~2~, cannot associate with Prr1 and can only trigger transcription of the drug resistance genes. (**C**) Similarly, in cells lacking Prr1, H~2~O~2~-oxidized Pap1 will only be able to activate drug resistance genes.

We have classified as 'drug tolerance genes' all those which are expressed upon nuclear Pap1 accumulation, but which do not require Pap1 oxidation or the presence of Prr1: *caf5, obr1* and *SPCC663.08c.* In fact, over-expression of the efflux pump Caf5 alone seems to be sufficient to explain the drug resistant phenotype ([@gks141-B17]). The *obr1* gene product, one of the first polypeptides which Pap1-dependent over-expression was detected in drug resistant strains ([@gks141-B27]), was soon discarded as mediator of the multidrug resistance phenotype ([@gks141-B15]), although its function is still unknown. Regarding the uncharacterized gene product SPCC663.08c, it has weak similarity to rat carbonyl reductase 1, which using a short chain dehydrogenase domain may catalyse the reduction of prostaglandins, steroids and ketone-containing xenobiotics.

Prr1 belongs to the two-component systems, which in *S. pombe* consists on three histidine kinases, a unique phosphotransmitter protein Mpr1 and two response regulators, Mcs4 and Prr1 \[for a review, see ([@gks141-B28])\]. It has recently been shown that the upstream two-component regulation of Prr1 is required for the response of cells to high levels of H~2~O~2~, which is mediated by the Sty1-Atf1 pathway ([@gks141-B29]). On the contrary, we suspect that regulation of Prr1 by Mpr1 is not required for activation of Pap1-dependent genes, since cells lacking the phosphotransmitter Mpr1 can properly induce both *caf5* and *trr1* ([Supplementary Figure S2A](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)), and the H~2~O~2~-dependent recruitment of Prr1 to both sets of promoters in cells lacking Mpr1 is very similar to that of wild-type cells ([Supplementary Figure S2B](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)). Similarly, phosphorylation of the Prr1 *S. cerevisiae* homologue, SKN7, has been shown to be dispensable to trigger the oxidative stress response genes ([@gks141-B30]). Fission yeast cells lacking Prr1 are not only sensitive to H~2~O~2~ (Prr1 contributes to the regulation of both Sty1-Atf1-global stress genes and Pap1-dependent antioxidant genes, as characterized here), but are sterile since they are unable to induce *ste11* expression, coding for a master regulator of the meiotic pathway ([@gks141-B31]).

We believe that oxidation of Pap1 not only hinders its Crm1-recognizing domain which causes its accumulation at the nucleus, but also exposes a Prr1-interacting domain, which may contribute to Prr1 participating in the activation of the Pap1-dependent genes rather than on its other reported cellular functions, similarly to what has been described for the budding yeast homologues SKN7 and YAP1 ([@gks141-B32]). It is worth pointing out that these two *S. cerevisiae* transcription factors, SKN7 and YAP1, orthologues of Prr1 and Pap1, respectively, have been shown to co-regulate several stress genes ([@gks141-B33]). They were both described to be important for wild-type tolerance to H~2~O~2~, but differentially required for cadmium resistance, and to co-operate in the induction of only a subset of H~2~O~2~-dependent proteins ([@gks141-B34]). Even though several reports have been focused on the identification of SNK7 and YAP1 DNA binding sites ([@gks141-B35; @gks141-B36; @gks141-B37]), or in the protein domains involved in their putative hetero-dimerization ([@gks141-B32]), the H~2~O~2~-mediated oxidation of YAP1 has never been demonstrated to be required for its association with SKN7.

How is Prr1 contributing to the regulation of Pap1-dependent antioxidant genes? We have evidences suggesting that Prr1 enhances the access or affinity of Pap1 for the antioxidant promoters, but may also contribute to transcriptional up-regulation of these genes as a transcription factor. On one hand, Pap1 recruitment to the *trr1, srx1* and *ctt1* promoters is severely impaired in the absence of Prr1 ([Figure 3](#gks141-F3){ref-type="fig"}E). We suspect that the access/affinity of Pap1 alone for the drug resistance promoters is high enough in the absence of Prr1 as to allow Pol II transcription, whereas association with Prr1 is required to enhance the recruitment of the Prr1-Pap1 complex to the antioxidant promoters. An *in vivo* confirmation of this hypothesis arises from the comparison of gene induction in strains expressing different concentrations of Pap1. As observed in [Supplementary Figure S3AB](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1), increasing 10-fold the endogenous concentration of Pap1 compensates the low affinity of the reduced/nuclear GFP-Pap1.C523D mutant, increases promoter occupancy, and allows the activation of the antioxidant set of genes. On the contrary, strong over-expression of Prr1 in cells lacking Pap1 does not trigger gene induction ([Supplementary Figure S3C](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)). The search for specific *cis* elements between both types of promoters which would validate the different affinities for Pap1 or Pap1-Prr1 is in progress. On the other hand, Prr1 may also contribute to the transcriptional up-regulation of antioxidant genes by recruiting some chromatin modifiers required at those promoters, or by establishment of specific contacts with Pol II: a greatly diminished but reproducible binding of Pap1 to antioxidant promoters can still be detected *in vivo* by ChIP in cells lacking Prr1 ([Figure 3](#gks141-F3){ref-type="fig"}E, right panel), whereas up-regulation of the mRNA antioxidant genes is completely abolished in this strain, as determined by northern blot ([Figure 3](#gks141-F3){ref-type="fig"}C, *Δprr1* strain, *trr1, ctt1, srx1* probes). That seems to indicate that the presence of Prr1, and not only of Pap1, at those promoters is required for transcriptional activation of this subset of genes. It is worth mentioning that Prr1 binds to Pap1-dependent promoters only after association with oxidized Pap1, as determined by ChIP ([Figure 4](#gks141-F4){ref-type="fig"}).

In conclusion, while oxidation of Pap1 contributes to the activation of two distinct sets of genes, induction of the drug resistance ones can be accomplished when non-oxidized Pap1 is accumulated in the nucleus. It is worth mentioning that Pap1 responds to peroxides by means of very exposed cysteine residues, which have already been reported to also react with alkylating agents such as diethylmaleate ([@gks141-B11]). This modified Pap1 protein also localizes in the nucleus, and importantly enough only triggers the drug tolerance genes ([Supplementary Figure S4A](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)), what suggests that defence against this drug may only require a partial and smaller gene expression program for adaptation. Similarly, drugs such as leptomycin B inhibit Crm1 function through covalent modification of some essential cysteine residues in this exportin ([@gks141-B38]); under those circumstances, Pap1 accumulation specifically triggers the drug resistance, but not the antioxidant, gene response ([Supplementary Figure S4B](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1)).
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[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gks141/DC1) are available at NAR Online: Supplementary Table 1, Supplementary Figures 1--4 and Supplementary References \[39\].
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